AstraZeneca Stock Down On Weak Q1 Profit; Backs FY22 View

Shares of AstraZeneca PLC were losing more than 1 percent in London trading and around 2 percent in pre-market activity on Nasdaq after the British drug major reported Friday sharply lower profit in its first quarter, despite increased revenues. Further, the company reiterated fiscal 2022 guidance at constant exchange rates. Core earnings per share is expected to increase by a mid-to-high twenties

from RTT - Top Story https://ift.tt/ZUR7Ced
via IFTTT